Center For Aids Research

CE Outcomes LLC, based in Birmingham, AL, has been a strategic partner for healthcare organizations since 2001, focusing on the dissemination of effective continuing education and medical information resources for clinicians and patients. The company actively engages in research and development, contributing to various publications and posters that address critical healthcare topics. With a commitment to enhancing clinical practice, CE Outcomes participates in conferences and produces insightful articles that explore patient experiences and educational needs across diverse medical fields. Their work emphasizes the importance of evidence-based care and the optimization of multidisciplinary approaches in healthcare management. Generated from the website

Central Alabama Research LLC, led by Mr. McLean and his experienced research staff, specializes in conducting clinical research trials with over 30 years of expertise. With a focus on providing high-quality research services, the team at Central Alabama Research LLC is dedicated to advancing medical knowledge and improving patient care through their trial work. Generated from their website's infomation

Pinnacle Research Group, LLC - Clinical research site for Rheumatoid arthritis, Diabetes, Hypertension, Phase III studies Clinical research site. Medical and Clinical Drug Testing and Trials. Intent to Treat Patient Populations. We are a Phase I unit capable of Phase II studies and Phase III studies Pinnacle Research Group Pinnacle Research Group, is a multi-specialty clinical trials organization We conduct Phase I - IV clinical drug and device studies over a broad therapeutic area, with particular interest in early phase development projects. Our facilities include inpatient capabilities with sleeping, food preparation, diagnostics, and medical emergency capabilities. Our site has been subjected to review and audit by organizations including Institutional Review Boards ( 2 ), Sponsors ( 6 ), and the Food and Drug Administration ( 2 ). Results of audits have been positive, with no citations, remedial actions, and no Form 483 ( FDA ).